These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9363365)

  • 1. Preventative and therapeutic effects of AE0047 on renal injury in stroke-prone spontaneously hypertensive rats.
    Hayashi K; Koyama M; Kido H; Egi Y; Kubo Y; Shinyama H; Iwamoto M; Nakamura N; Kagitani Y
    Clin Exp Pharmacol Physiol; 1997 Nov; 24(11):831-40. PubMed ID: 9363365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ohtaki Y; Fujino Y; Egi Y; Ebisu H; Inoue S; Yamanaga K; Uchida T; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against endothelial abnormalities by a novel calcium channel blocker, AE0047, in stroke-prone spontaneously hypertensive rats.
    Nishikawa M; Kubo Y; Kido H; Nakayama T; Nakamura N
    Gen Pharmacol; 1999 Mar; 32(3):299-305. PubMed ID: 10211583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of AE0047, a novel calcium antagonist, on progression of brain damage after stroke in stroke-prone spontaneously hypertensive rats.
    Shinyama H; Nagai H; Kawamura T; Narita Y; Nakamura N; Kagitani Y
    Gen Pharmacol; 1998 Mar; 30(3):379-86. PubMed ID: 9510090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats.
    Suganami T; Mori K; Tanaka I; Mukoyama M; Sugawara A; Makino H; Muro S; Yahata K; Ohuchida S; Maruyama T; Narumiya S; Nakao K
    Hypertension; 2003 Dec; 42(6):1183-90. PubMed ID: 14670979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.
    Shinyama H; Nagai H; Kawamura T; Narita Y; Uchida T; Watanabe M; Kagitani Y
    J Pharmacol Exp Ther; 1995 Feb; 272(2):911-9. PubMed ID: 7853209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of benidipine on the development of hypertension and renal lesions in salt-loaded stroke-prone spontaneously hypertensive rats.
    Nito M; Sato H; Hara T; Karasawa A; Yamada K; Ohta Y
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S337-8. PubMed ID: 9072418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats.
    Ueda M; Masui M; Kawakami M; Matsunaga K; Gemba T; Ninomiya M; Nakano A; Torii M; Adachi I; Ito H
    Arzneimittelforschung; 1993 Dec; 43(12):1291-303. PubMed ID: 8141816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats.
    Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Nako H; Ogawa H; Kim-Mitsuyama S
    J Hypertens; 2010 Jun; 28(6):1321-9. PubMed ID: 20224431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term treatment with the calcium antagonist AE0047 on cerebrovascular autoregulation and hypertrophy in spontaneously hypertensive rats.
    Shinyama H; Nagai H; Kawamura T; Narita Y; Nakamura N; Kagitani Y
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):616-22. PubMed ID: 9388044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive effects of long-term treatment with AE0047, a novel long-lasting calcium antagonist, in hypertensive models of rats and dogs].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ebisu H; Egi Y; Shinyama H; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):291-301. PubMed ID: 9253776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the calcium antagonist AE0047 on the development of neurological deficit and infarction after middle cerebral artery occlusion in stroke-prone spontaneously hypertensive rats.
    Shinyama H; Kawamura T; Iwamoto M; Egi Y; Tanaka H; Kawabata Y; Nakamura N; Kagitani Y
    J Pharm Pharmacol; 1997 Sep; 49(9):919-24. PubMed ID: 9306262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
    Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
    Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na+/K+-ATPase alpha isoforms expression in stroke-prone spontaneously hypertensive rat heart ventricles: effect of salt loading and lacidipine treatment.
    Quintas LE; Noël F; Wibo M
    Eur J Pharmacol; 2007 Jun; 565(1-3):151-7. PubMed ID: 17451677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiloride reduces stroke and renalinjury in stroke-prone hypertensive rats.
    Sepehrdad R; Chander PN; Oruene A; Rosenfeld L; Levine S; Stier CT
    Am J Hypertens; 2003 Apr; 16(4):312-8. PubMed ID: 12670749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats.
    Rocha R; Chander PN; Zuckerman A; Stier CT
    Hypertension; 1999 Jan; 33(1 Pt 2):232-7. PubMed ID: 9931110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect.
    Stier CT; Chander P; Gutstein WH; Levine S; Itskovitz HD
    Am J Hypertens; 1991 Aug; 4(8):680-7. PubMed ID: 1930850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a selective endothelin A-receptor antagonist, BQ-123, in salt-loaded stroke-prone spontaneously hypertensive rats.
    Okada M; Kobayashi M; Maruyama H; Takahashi R; Ikemoto F; Yano M; Nishikibe M
    Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):763-8. PubMed ID: 8575114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker.
    Zhan Y; Kim S; Kawano H; Iwao H
    Hypertens Res; 2002 Mar; 25(2):295-301. PubMed ID: 12047046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.